Eliaz Therapeutics Inc.

Biotechnology company · Santa Rosa, California, United States

Eliaz Therapeutics Inc. is a biotechnology company headquartered in Santa Rosa, California, United States. Its earliest recorded incorporation is in 2015. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.9 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $850,000 sold in a notice filed in 2025.

www.eliaztherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Eliaz Therapeutics at a glance

Typebiotechnology company
HeadquartersSanta Rosa, California, United States
Earliest incorporation on record2015
Employees (self-reported, 2022)5
SEC CIK1682808, 2042609

What does Eliaz Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $1.9 million in total (2018 to 2022). NIH funding came from the National Institute of General Medical Sciences.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $850,000 sold (2025).

Frequently asked questions about Eliaz Therapeutics

Where is Eliaz Therapeutics headquartered?

Eliaz Therapeutics Inc. is headquartered in Santa Rosa, California, United States.

What does Eliaz Therapeutics do?

Eliaz Therapeutics Inc. is a biotechnology company.

When was Eliaz Therapeutics founded?

The earliest incorporation on record for Eliaz Therapeutics Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences